The short answer is yes, particularly during menopause. In fact, we can blame a lot on hormonal changes, from unexpected ...

Prescriptions for hormone therapy dropped after a study suggested it could increase health risks like cancer. But experts say ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

If you're struggling to conceive, you may be offered fertility drugs. Find out which ones are available for women, how they ...

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

A three-drug combination targeting aggressive advanced breast cancer could potentially double the amount of time patients ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

The drug has a half-life of approximately 28 h. Raloxifene is an estrogen agonist in bone, where it exerts an antiresorption effect. The drug does not cause endometrial stimulation and ...

Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men With Biochemically Recurrent Prostate Cancer Aug. 22, 2024 — The anti-cancer drug olaparib may be effective in ...

Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.

(HealthDay News) — Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the ...

My daughter faced the difficult decision of balancing the potential benefits and risks of cancer treatment, including the long-term heart complications associated with Herceptin.